KEYTRUDA conc perf 100 mg/4ml flac 2 pce
7680662310025
CH-66231
L01FF02
07.16.1.
Reimbursement limitations:
KEYTRUDA.01
1L NSCLC (monothérapie) KN024
(avec modèle de prix)
Monothérapie en première ligne du cancer du …
1 / 3
google
Details
- Product number
- 6623101
- CPT
- -
- Packaging group
- 2
- Unit
- Durchstechflasche(n)
- Composition
- pembrolizumabum 100 mg, histidinum, histidini hydrochloridum monohydricum, polysorbatum 80, saccharum, aqua ad iniectabile q.s. ad solutionem pro 4 ml.
Articles (1)
Keytruda 100 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
2
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 4294.10
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/05/2020
Authorization holder
MSD Merck Sharp & Dohme AG
6005 Luzern
Authorization information
- Swissmedic authorization number
- 66231
- Drug name
- Keytruda, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01FF02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 22/02/2017
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- KEYTRUDA 100 mg/4 ml conc perf 100 mg 2 pce
- Description (DE)
- KEYTRUDA 100 mg/4 ml Konz Inf 100 mg 2 Stk
- Market launch
- 22/02/2017
- Narcotic (BTM)
- No